A Phase II Trial of RP-101 for the Treatment of Moderate to Severe Chronic Dry Eye Disease in Postmenopausal Women
Phase of Trial: Phase II
Latest Information Update: 09 Jul 2018
At a glance
- Drugs RP-101-Redwood Pharma (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- Sponsors Redwood Pharma
- 09 Jul 2018 According to a Redwood Pharma media release, the company has submitted clinical trial application to a national authority and ethical committee to start this trial in Q3 assuming required approvals have been granted.
- 26 Apr 2018 According to a Redwood Pharma media release, the capital injection provided by the company, now allows to initiate final preparations for this trial.
- 01 Mar 2018 New trial record